GEORGE H. CONRADES

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Aimee Weast by Aimee Weast, Attorney in Fact for George H. Conrades (POA filed 6/4/19)
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GEORGE H. CONRADES:

Company Role Class Num Shares Value Price $ Report Date Ownership
ORACLE CORP Director Common Stock 38,456 $8,209,971 $213.49 17 Jun 2025 Direct
Cyclerion Therapeutics, Inc. Director Stock Option (Right to Buy) 20,000 14 Jun 2022 Direct
ORACLE CORP Director Restricted Stock Unit 0 31 May 2025 Direct
ORACLE CORP Director Stock Option 0 21 Apr 2025 Direct

Insider Reports Filed by GEORGE H. CONRADES

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ORCL ORACLE CORP 17 Jun 2025 1 -$1,744,000 4 Director 20 Jun 2025, 17:49
ORCL ORACLE CORP 31 May 2025 3 $0 4 Director 03 Jun 2025, 17:15
ORCL ORACLE CORP 21 Apr 2025 2 +$978,525 4 Director 23 Apr 2025, 16:57
ORCL ORACLE CORP 31 May 2024 3 $0 4 Director 03 Jun 2024, 19:21
ORCL ORACLE CORP 03 May 2024 3 -$1,479,600 4 Director 06 May 2024, 16:52
ORCL ORACLE CORP 01 May 2024 3 -$1,852,690 4 Director 02 May 2024, 20:35
ORCL ORACLE CORP 10 Nov 2023 2 -$524,829 4 Director 13 Nov 2023, 19:08
ORCL ORACLE CORP 31 May 2023 3 $0 4 Director 02 Jun 2023, 18:30
ORCL ORACLE CORP 22 Dec 2022 1 $0 4 Director 23 Dec 2022, 13:36
CYCN Cyclerion Therapeutics, Inc. 14 Jun 2022 1 $0 4 Director 16 Jun 2022, 20:56
ORCL ORACLE CORP 31 May 2022 3 $0 4 Director 02 Jun 2022, 16:36
CYCN Cyclerion Therapeutics, Inc. 24 Jun 2021 1 $0 4 Director 28 Jun 2021, 17:11
ORCL ORACLE CORP 31 May 2021 3 $0 4 Director 02 Jun 2021, 18:37